Maxim Group Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $45
Portfolio Pulse from Benzinga Newsdesk
Maxim Group has initiated coverage on Nutex Health with a Buy rating and set a price target of $45. This suggests a positive outlook for the company's stock.
September 18, 2024 | 12:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Maxim Group has initiated coverage on Nutex Health with a Buy rating and a price target of $45, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a high price target by Maxim Group suggests confidence in Nutex Health's future performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100